Carlos Puche-Carretero
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Co-targeting SRC overcomes resistance to BRAF inhibitors in colorectal cancer.
Journal: British journal of cancer
Published: October 07, 2024
Metabolomic profile of neuroendocrine tumors identifies methionine, porphyrin, and tryptophan metabolisms as key dysregulated pathways associated with patient survival.
Journal: European journal of endocrinology
Published: June 22, 2023
Advances in the Treatment of Gastroenteropancreatic Neuroendocrine Carcinomas: Are we Moving Forward?
Journal: Endocrine reviews
Published: November 30, 2022
MicroRNA signature and integrative omics analyses define prognostic clusters and key pathways driving prognosis in patients with neuroendocrine neoplasms.
Journal: Molecular oncology
Published: July 27, 2022
Comprehensive Plasma Metabolomic Profile of Patients with Advanced Neuroendocrine Tumors (NETs). Diagnostic and Biological Relevance.
Journal: Cancers
Published: April 29, 2021
Beyondcell: targeting cancer therapeutic heterogeneity in single-cell RNA-seq data.
Journal: Genome medicine
Published: March 26, 2021
DREIMT: a drug repositioning database and prioritization tool for immunomodulation.
Journal: Bioinformatics (Oxford, England)
Published: August 16, 2019
The correlation between immune subtypes and consensus molecular subtypes in colorectal cancer identifies novel tumour microenvironment profiles, with prognostic and therapeutic implications.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 04, 2019
vulcanSpot: a tool to prioritize therapeutic vulnerabilities in cancer.
Journal: Bioinformatics (Oxford, England)
Published: November 26, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026